India's CDSCO forms AI expert committee for pharma regulation

India's Central Drugs Standard Control Organisation (CDSCO) has formed an expert committee on artificial intelligence, DCGI chief Rajeev Singh Raghuvanshi said on September 18. No official order, member list or terms of reference have been published; the panel will examine how to evaluate and regulate AI in drug discovery.

• CDSCO has not published the committee's order, members or timeline
• The panel will discuss evaluating and regulating AI in drug discovery
• In August the Health Ministry told Parliament CDSCO does not use AI for approvals
• CDSCO already regulates AI medical device software and pilots AI for application review